Association of English language proficiency and breast cancer oncologic outcomes
Clicks: 5
ID: 325324
2026
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Emerging Content
0.6
/100
5 views
2 readers
AI Quality Assessment
Not analyzed
Readership in this journal
EmergingRanked #38 of 50 articles by views in jnci cancer spectrum
Most read
Least read
Bar heights use a square-root scale.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
Few studies have compared oncologic outcomes directly between English-speaking (ES) and non-English-speaking (NES) patients. We performed a matched cohort study of Stage I-III breast cancer patients with ES patients propensity matched 3:1 to NES patients based on age, tumor stage, nodal involvement, and receipt of adjuvant therapy. Patients were categorized as ES or NES based on preferred language documented in the electronic medical record. Primary outcomes were locoregional recurrence (LRR), disease-free survival (DFS), and overall survival (OS). Among 2768 patients (2076 ES; 692 NES), median age at diagnosis was 62 years (range, 25-94). 10-year LRR was 9.5% versus 13% (P = 0.032), 10-year DFS was 71% versus 63% (P = 0.008), and 10-year OS was 79% versus 74% (P = 0.12) for ES and NES patients, respectively. These findings suggest NES patients may have inferior breast cancer outcomes, even in highly resourced academic environments. These findings highlight the need for targeted interventions beyond language assistance.
| Reference Key |
openalex_W7203708832
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | R. Ravella, Lillian A. Boe, Anushri Mahabir, Boris A Mueller, Emma N. Hahesy, J Isabelle Choi, Anyi Li, Simon N Powell, Atif J Khan, Lior Z Braunstein |
| Journal | jnci cancer spectrum |
| Year | 2026 |
| DOI |
10.1093/jncics/pkag079
|
| URL | |
| Keywords | Keywords not found |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.